Cited by 217Genetic Associations and EpidemiologyGenomics and Rare DiseasesDiabetes and associated disorders

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes

Open access

Abstract

We have identified a variant in ADCY3 (encoding adenylate cyclase 3) associated with markedly increased risk of obesity and type 2 diabetes in the Greenlandic population. The variant disrupts a splice acceptor site, and carriers have decreased ADCY3 RNA expression. Additionally, we observe an enrichment of rare ADCY3 loss-of-function variants among individuals with type 2 diabetes in trans-ancestry cohorts. These findings provide new information on disease etiology relevant for future treatment strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41588-017-0022-7

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 4

  1. Lohmueller, K. E. et al. Am. J. Hum. Genet. 93, 1072–1086 (2013). · DOI
  2. Bjerregaard, P. et al. Int. J. Circumpolar Health 62 (Suppl. 1), 3–79 (2003).
  3. Bjerregaard, P. Inuit Health in Transition—Greenland Survey 2005–2010 2nd edn (National Institute of Public Health, Copenhagen, 2011).
  4. Alexander, D. H., Novembre, J. & Lange, K. Genome Res. 19, 1655–1664 (2009). · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Grarup, N., Moltke, I., Andersen, M. K., Dalby, M., Vitting-Seerup, K., Kern, T., Mahendran, Y., Jørsboe, E., Larsen, C. V. L., Dahl-Petersen, I. K., Gilly, A., Suveges, D., Dedoussis, G., Zeggini, E., Pedersen, O., Andersson, R., Bjerregaard, P., Jørgensen, M. E., Albrechtsen, A., & Hansen, T.
Affiliations
  • University of Copenhagen (DK)
  • Ilisimatusarfik (GL)
  • Wellcome Sanger Institute (GB)
  • Harokopio University of Athens (GR)
Corresponding author
  • Jørgensen, Marit E.
  • Albrechtsen, Anders
  • Hansen, Torben
Venue
Nature Genetics
Published
2018-01-08
Volume
50
Issue
2
Pages
172-174
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2781623981
Cited by
216
References
43
Citations by year
2026: 18 · 2025: 20 · 2024: 28 · 2023: 24 · 2022: 18 · 2021: 31 · 2020: 46 · 2019: 12 · 2018: 19
FWCI
16.83
Type
journal article
Language
en
Open access
Locations
  • Nature Genetics (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, other-oa)
Funders
  • Broad Institute
  • Steno Diabetes Center Copenhagen (SDCC 3. B Epidemiology)
  • European Commission (HORIZON2020)
  • Lundbeckfonden (R215‐2015‐4174)
  • Novo Nordisk (NNF16OC0019986)
  • Danmarks Frie Forskningsfond (DFF-4090-00244, DFF-4181- 00383, 6108-00038B)
  • Copenhagen Graduate School for Nanoscience and Nanotechnology
  • Novo Nordisk Fonden (NNF16OC0019986, #NNF17OC0028136, NNF17SH0027192, NNF15SA0018486, NNFCC0018486, NNF15OC0017918)
  • Simon Fougner Hartmanns Familiefond
  • Novo Nordisk Foundation Center for Basic Metabolic Research
  • H. Lundbeck A/S
  • Medical Research Council
  • Comisión de Investigaciones Científicas
  • H2020 European Research Council (638173)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
ADCY3, loss-of-function mutations, obesity, type 2 diabetes, splice acceptor site, RNA expression, Greenlandic Inuit, rare variants, disease risk
MeSH terms
Loss of Function Mutation, Adenylyl Cyclases, Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Inuit, Female, Gene Frequency, Genotype, Greenland, Humans, Male, Middle Aged, Obesity, Risk Factors, Cohort Studies, Case-Control Studies, Genetic Predisposition to Disease, Genome-Wide Association Study, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review